hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature.


Growing evidence suggests that only a fraction of prostate cancers detected clinically are potentially lethal. An important clinical issue is identifying men with indolent cancer who might be spared aggressive therapies with associated morbidities. Previously, using microarray analysis we defined 3 molecular subtypes of prostate cancer with different gene… (More)
DOI: 10.1097/PAS.0b013e318124a865


3 Figures and Tables